Cargando…

A Nucleotide Metabolism-Related Gene Signature for Risk Stratification and Prognosis Prediction in Hepatocellular Carcinoma Based on an Integrated Transcriptomics and Metabolomics Approach

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide. The in-depth study of genes and metabolites related to nucleotide metabolism will provide new ideas for predicting the prognosis of HCC patients. This study integrated the transcriptome data of different cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Tianfu, Liu, Jifeng, Ma, Shurong, Wang, Mimi, Yuan, Qihang, Huang, Anliang, Wu, Zeming, Shang, Dong, Yin, Peiyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673507/ https://www.ncbi.nlm.nih.gov/pubmed/37999212 http://dx.doi.org/10.3390/metabo13111116

Ejemplares similares

Integration of transcriptomics, proteomics, and metabolomics data to reveal HER2-associated metabolic heterogeneity in gastric cancer with response to immunotherapy and neoadjuvant chemotherapy
por: Yuan, Qihang, et al.
Publicado: (2022)

Tissue metabolomics identified new biomarkers for the diagnosis and prognosis prediction of pancreatic cancer
por: Liu, Chang, et al.
Publicado: (2022)

Metabolomics study identified bile acids as potential biomarkers for gastric cancer: A case control study
por: Pan, Chen, et al.
Publicado: (2022)

The combined signatures of the tumour microenvironment and nucleotide metabolism-related genes provide a prognostic and therapeutic biomarker for gastric cancer
por: Liu, Jifeng, et al.
Publicado: (2023)

An Integrated Metabolomic Study of Osteoporosis: Discovery and Quantification of Hyocholic Acids as Candidate Markers
por: Deng, Dawei, et al.
Publicado: (2021)

Novel Hypoxia-Related Gene Signature for Risk Stratification and Prognosis in Hepatocellular Carcinoma
por: Li, Quanxiao, et al.
Publicado: (2021)

Single-cell sequencing and bulk RNA sequencing reveal a cell differentiation-related multigene panel to predict the prognosis and immunotherapy response of hepatocellular carcinoma
por: Liu, Jifeng, et al.
Publicado: (2023)

A novel NHEJ gene signature based model for risk stratification and prognosis prediction in hepatocellular carcinoma
por: Lin, Zhu, et al.
Publicado: (2023)

A novel tumor immunotherapy-related signature for risk stratification, prognosis prediction, and immune status in hepatocellular carcinoma
por: Sun, Jianping, et al.
Publicado: (2023)

Integrated analysis of transcriptomics and metabolomics of peach under cold stress
por: Li, Yonghong, et al.
Publicado: (2023)

Individualized prognosis stratification in muscle invasive bladder cancer: A pairwise TP53-derived transcriptome signature
por: Liu, Hua-Ping, et al.
Publicado: (2023)

Identification of a nucleotide metabolism-related signature to predict prognosis and guide patient care in hepatocellular carcinoma
por: Li, Yu, et al.
Publicado: (2023)

Identification of a DNA Damage Response and Repair-Related Gene-Pair Signature for Prognosis Stratification Analysis in Hepatocellular Carcinoma
por: Chen, Yi, et al.
Publicado: (2022)

A T-cell-related signature for prognostic stratification and immunotherapy response in hepatocellular carcinoma based on transcriptomics and single-cell sequencing
por: Chen, Xu, et al.
Publicado: (2023)

Novel immune‐related signature for risk stratification and prognosis in prostatic adenocarcinoma
por: Zhao, Hai‐Bo, et al.
Publicado: (2021)

An Integrating Immune-Related Signature to Improve Prognosis of Hepatocellular Carcinoma
por: Zhu, Rui, et al.
Publicado: (2020)

Development of somatic mutation signatures for risk stratification and prognosis in lung and colorectal adenocarcinomas
por: Menor, Mark, et al.
Publicado: (2019)

Transcriptomic signature associated with RNA-binding proteins for survival stratification of laryngeal cancer
por: Shen, Yujie, et al.
Publicado: (2022)

Transcriptomic and Metabolomic Profiling in Helicobacter pylori–Induced Gastric Cancer Identified Prognosis- and Immunotherapy-Relevant Gene Signatures
por: Liu, Duanrui, et al.
Publicado: (2021)

HR-MS Based Untargeted Lipidomics Reveals Characteristic Lipid Signatures of Wilson’s Disease
por: Zhi, Yixiao, et al.
Publicado: (2021)

Novel immune-related gene signature for risk stratification and prognosis prediction in ovarian cancer
por: Fei, Hongjun, et al.
Publicado: (2023)

An Apoptotic Gene Signature for the Prognosis of Hepatocellular Carcinoma
por: Chen, Kunlun, et al.
Publicado: (2021)

Prognostic and predictive role of a metabolic rate‐limiting enzyme signature in hepatocellular carcinoma
por: Wang, Zhangding, et al.
Publicado: (2021)

Metabolomics-Guided Identification of a Distinctive Hepatocellular Carcinoma Signature
por: Tambay, Vincent, et al.
Publicado: (2023)

Identification and verification of the ferroptosis- and pyroptosis-associated prognostic signature for low-grade glioma
por: Wang, Jie, et al.
Publicado: (2022)

Metabolic Signature of Articular Cartilage Following Mechanical Injury: An Integrated Transcriptomics and Metabolomics Analysis
por: Southan, Jennifer, et al.
Publicado: (2020)

A novel stemness-hypoxia-related signature for prognostic stratification and immunotherapy response in hepatocellular carcinoma
por: Zhang, Genhao, et al.
Publicado: (2022)

Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma
por: Zhang, Mingwei, et al.
Publicado: (2020)

Stromal-Immune Score-Based Gene Signature: A Prognosis Stratification Tool in Gastric Cancer
por: Wang, Hao, et al.
Publicado: (2019)

An Aging-Related Gene Signature-Based Model for Risk Stratification and Prognosis Prediction in Breast Cancer
por: Yuan, Jing, et al.
Publicado: (2021)

An Aging-Related Gene Signature-Based Model for Risk Stratification and Prognosis Prediction in Lung Adenocarcinoma
por: Xu, Qian, et al.
Publicado: (2021)

Risk stratification and prognosis prediction based on inflammation‐related gene signature in lung squamous carcinoma
por: Zhai, Wenyu, et al.
Publicado: (2022)

Gut Microbiome and the Role of Metabolites in the Study of Graves’ Disease
por: Liu, Haihua, et al.
Publicado: (2022)

A genomic enhancer signature associates with hepatocellular carcinoma prognosis
por: Jeon, Ah-Jung, et al.
Publicado: (2023)

Mutational signatures representative transcriptomic perturbations in hepatocellular carcinoma
por: Wu, Qiong, et al.
Publicado: (2022)

Preoperative Radiomics Analysis of Contrast-Enhanced CT for Microvascular Invasion and Prognosis Stratification in Hepatocellular Carcinoma
por: Xu, Tingfeng, et al.
Publicado: (2022)

Metabolic Reprogramming and Risk Stratification of Hepatocellular Carcinoma Studied by Using Gas Chromatography–Mass Spectrometry-Based Metabolomics
por: Fang, Chengnan, et al.
Publicado: (2022)

Reference-free transcriptome signatures for prostate cancer prognosis
por: Nguyen, Ha T.N., et al.
Publicado: (2021)

The single-nucleotide polymorphisms in CHD5 affect the prognosis of patients with hepatocellular carcinoma
por: Zhu, Xiao, et al.
Publicado: (2017)

Molecular subtype identification and prognosis stratification by a metabolism-related gene expression signature in colorectal cancer
por: Lin, Dagui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fia08rj07hsmc775olbc7im6cd